A series of xanthine derivatives targeting DPP-IV and GPR119 was synthesized.
Systematic optimization led to the identification of dual modulator 20i.
Compound 20i had a selective DPP-IV inhibition and good GPR119 agonism activity.
Compound 20i had a favorable metabolic stability.
Insulinotropic effect of compound 20i was glucose-concentration dependent.